SLC17A5 and lung cancer: In NCI-H1703 and A549 cells, SYL2158 (66) induced NSD3 degradation and effectively inhibited H3K36 methylation, the expression of NSD3-associated genes, and clone formation in lung cancer cells, in addition to possessing good selectivity over the other two NSD proteins (NSD1 and NSD2).